Mitomycin synthetic studies: Stereocontrolled and convergent synthesis of a fully elaborated aziridinomitosane

Journal of Organic Chemistry

Volumn 69, Issue 21, 2004, Pages 7309-7316

  Coleman, Robert S ^a   Felpin, François Xavier ^a   Chen, Wei ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL ANALYSIS; MOLECULAR DYNAMICS; SYNTHESIS (CHEMICAL);

ANTITUMOR AGENTS; MITOMYCIN; SYNTHETIC ROUTE;

ORGANIC COMPOUNDS;

9A DESMETHOXYMITOMYCIN A; ANTINEOPLASTIC AGENT; AZIRIDINE DERIVATIVE; AZIRIDINOMITOSANE; DNA; IMINE; INDOLE DERIVATIVE; MITOMYCIN DERIVATIVE; TETRAHYDROPYRROLO[1,2 A]INDOLE DERIVATIVE; TIN DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CROSS LINKING; DIASTEREOISOMER; DRUG ISOLATION; DRUG STRUCTURE; DRUG SYNTHESIS; STEREOCHEMISTRY;

AZIRIDINES; CYCLIZATION; MITOMYCIN; MITOMYCINS; MODELS, MOLECULAR; MOLECULAR CONFORMATION; STEREOISOMERISM;

EID: 5444237056     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo048924i     Document Type: Article

References (49)

1. Hata, T.; Hoshi, T.; Kanamori, K.; Matsumae, A.; Sano, Y.; Shima, T.; Sugawara, R. J. Antibiot. Ser. A 1956, 9, 141.
2. (a) Bradner, W. T. Cancer Treat. Rev. 2001, 27, 35.
3. (b) Tomasz, M.; Palom, Y. Pharmacol. Ther. 1997, 76, 73.
4. Remers, W. A. Mitomycins and porfiromycin. In The Chemistry of Antitumor Antibiotics; Wiley-Interscience: New York, 1979; pp 221-276.
5. Iyer, V. N.; Szybalski, W. Proc. Natl. Acad. Sci. U.S.A. 1963, 50, 355.
6. (a) Tomasz, M.; Lipman, R.; Chowdary, D.; Pawlak, J.; Verdine, G. L.; Nakanishi, K. Science 1987, 235, 1204.
7. (b) Tomasz, M.; Lipman, R.; McGuinness, B. F.; Nakanashi, K. J. Am. Chem. Soc. 1988, 110, 5892.
8. Mallard, J. T.; Weidner, M. F.; Raucher, S.; Hopkins, P. B. J. Am. Chem. Soc. 1990, 112, 3637.
9. Iyer, V. N.; Szybalski, W. Science 1964, 145, 55.
10. (a) Coleman, R. S. Curr. Opin. Drug Discovery Dev. 2001, 4, 435.
11. (b) Danishefsky, S. J.; Schkeryantz, J. M. Synlett 1995, 475.
12. (c) Fukuyama, T.; Yang, L. Total Synthesis of Mitomycins. In Studies in Natural Products Chemistry; Atta-ur-Rahman, Ed.; Elsevier: New York, 1993; pp 433-471.
13. (a) Fukuyama, T.; Nakatsubo, F.; Cocuzza, A. J.; Kishi, Y. Tetrahedron Lett. 1977, 4295.
14. (b) For a review of work from the Kishi group, see: Kishi, Y. J. Nat. Prod. 1979, 42, 9388.
15. (a) Fukuyama, T.; Yang, L. J. Am. Chem. Soc. 1987, 109, 7881.
16. (b) Fukuyama, T.; Yang, L. J. Am. Chem. Soc. 1989, 111, 8303.
17. (a) Uchida, I.; Takase, S.; Kayakiri, H.; Kiyoto, S.; Hashimoto, M.; Tada, T.; Koda, S.; Morimoto, Y. J. Am. Chem. Soc. 1987, 109, 4108.
18. (b) Shimomura, K.; Hirai, O.; Mizota, T.; Matsumoto, S.; Mori, J.; Shibayama, F.; Kikuchi, H. J. Antibiot. 1987, 40, 600.
19. Paz, M. M.; Hopkins, P. B. J. Am. Chem. Soc. 1997, 119, 5999.
20. (a) Ziegler, F. E.; Berling, M. Y. Tetrahedron Lett. 1998, 39, 2455.
21. (b) Danishefsky, S.; Berman, E. M.; Ciufolini, M.; Etheredge, S. J.; Segmuller, B. E. J. Am. Chem. Soc. 1985, 107, 3891.
22. (c) Kinoshita, S.; Uzu, K.; Nakano, K.; Shimizu, M.; Takahashi, T. J. Med. Chem. 1971, 14, 103.
23. Coleman, R. S.; Chen, W. Org. Lett. 2001, 3, 1141.
24. (a) Yin, J.; Buchwald, S. L. Org. Lett. 2000, 2, 1101.
25. (b) Wolfe, J. P.; Tomori, H.; Sadighi, J. P.; Yin, J.; Buchwald, S. L. J. Org. Chem. 2000, 65, 1158.
26. (c) Wolfe, J. P.; Buchwald, S. L. J. Org. Chem. 1997, 62, 1264.
27. (d) Åhman, J.; Buchwald, S. L. Tetrahedron Lett. 1997, 38, 6363.
28. Finley, K. T. The addition and substitution chemistry of quinones. In Chemistry of the Quinonoid Compounds; Patai, S., Ed., Wiley: New York, 1974; Vol. 2, pp 877-1144.
29. Viaud, M. C.; Rollin, P. Synthesis 1990, 130.
30. Taniguchi, T.; Ogasawara, K. Angew. Chem., Int. Ed. 1998, 37, 1136.
31. (a) Armas, P.; Francisco, C. G.; Suarez, E. Angew. Chem., Int. Ed. Engl. 1992, 31, 772.
32. (b) Armas, P.; Francisco, C. G.; Suarez, E. Tetrahedron Lett. 1992, 33, 6687.
33. (c) Armas, P.; Francisco, C. G.; Suarez, E. J. Am. Chem. Soc. 1993, 115, 8865.
34. (d) Francisco, C. G.; Freire, R.; Gonzalez, C. C.; Suarez, E. Tetrahedron: Asymmetry 1997, 8, 1971.
35. (a) Lal, B.; Pramanik, B.; Manhas, M. S.; Bose, A. K. Tetrahedron Lett. 1977, 1977.
36. (b) Shioiri, T.; Ninomiya, K.; Yamada, S. J. Am. Chem. Soc. 1972, 94, 6203.
37. (a) Schlingloff, G.; Sharpless, K. B. Asym. Oxid. React. 2001, 104.
38. (b) Andersson, M. A.; Epple, R.; Fokin, V. V.; Sharpless, K. B. Angew. Chem., Int. Ed. 2002, 41, 472.
39. (c) Fokin, V. V.; Sharpless, K. B. Angew. Chem., Int. Ed. 2001, 40, 3455.
40. (d) Rubin, A. E.; Sharpless, K. B. Angew. Chem., Int. Ed. Engl. 1997, 36, 2637.
41. (e) Li, G.; Angert, H. H.; Sharpless, K. B. Angew. Chem., Int. Ed. Engl. 1996, 35, 2813.
42. Fleming, I. Chemtracts 2001, 14, 405 and references therein.
43. Renz, M.; Meunier, B. Eur. J. Org. Chem. 1999, 737.
44. Tabuchi, T.; Inanaga, J.; Yamaguchi, M. Tetrahedron Lett. 1987, 28, 215.
45. 1H NMR and HRMS (ESI). The MS data confirmed the molecular formula and allowed at least some NMR assignments to be made. We found it essentially impossible to confirm the identity of reaction products using NMR as the sole method of characterization.
46. 2O, 25 °C, 87%] to afford the quinone 48, thereby validating the feasibility of maintaining the integrity of the aziridine ring system through this reaction sequence. (Diagram presented)
47. It proved impossible to remove a pyrrolidine tert-butyl carbamate once the C10 carbamate and/or the quinone were installed; intermediates possessing a benzyl carbamate protecting the pyrrolidine nitrogen could be converted to a quinone bearing system.
48. He, F.; Bo, Y.; Altom, J. D.; Corey, E. J. J. Am. Chem. Soc. 1999, 121, 6771.
49. Comparable syntheses of 1 or a closely related compound have required 32 total steps (20 linear)13a or 27 steps (27 linear).13b